KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Enterprise Value: 2016-2024

Historic Enterprise Value for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $2.4 billion.

  • Amneal Pharmaceuticals' Enterprise Value rose 17.54% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 billion, marking a year-over-year increase of 16.38%. This contributed to the annual value of $2.4 billion for FY2024, which is 33.03% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Enterprise Value stood at $2.4 billion for FY2024, which was up 33.03% from $1.8 billion recorded in FY2023.
  • Over the past 5 years, Amneal Pharmaceuticals' Enterprise Value peaked at $2.4 billion during FY2024, and registered a low of $603.1 million during FY2022.
  • Moreover, its 3-year median value for Enterprise Value was $1.8 billion (2023), whereas its average is $1.6 billion.
  • In the last 5 years, Amneal Pharmaceuticals' Enterprise Value slumped by 50.29% in 2022 and then surged by 200.18% in 2023.
  • Over the past 5 years, Amneal Pharmaceuticals' Enterprise Value (Yearly) stood at $1.0 billion in 2020, then grew by 16.63% to $1.2 billion in 2021, then tumbled by 50.29% to $603.1 million in 2022, then surged by 200.18% to $1.8 billion in 2023, then surged by 33.03% to $2.4 billion in 2024.